The senescence effect of zoledronate on three-dimensional oral mucosa model

Zoledronate (ZOL) is an antiresorptive bisphosphonate used to prevent bone loss in skeletal-related disorders, especially in patients with advanced cancer metastatic to bone. However, this medication led to an oral lesion known as medication-related osteonecrosis of the jaw (MRONJ) which also presen...

Full description

Saved in:
Bibliographic Details
Main Authors: Shaharuddin, Nur Bashira, Jones, Danial, Chai, Wen Lin
Format: Article
Published: Penerbit Universiti Kebangsaan Malaysia 2022
Subjects:
Online Access:http://eprints.um.edu.my/40454/
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first